1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid
C24H23ClN4O4 — CID 167509452
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid
1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid (PubChem CID 167509452) has the molecular formula C24H23ClN4O4 and a molecular weight of 466.93 g/mol. Its IUPAC name is 1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid.
Molecular Properties
| Compound Name | 1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid |
|---|---|
| PubChem CID | 167509452 |
| Molecular Formula | C24H23ClN4O4 |
| Molecular Weight | 466.93 g/mol |
| Exact Mass | 466.14 |
| IUPAC Name | 1-(1-acetylpiperidin-4-yl)-6-chloro-7-(5,7-dihydropyrrolo[3,4-b]pyridin-6-yl)-4-oxoquinoline-3-carboxylic acid |
| SMILES | CC(=O)N1CCC(n2cc(C(=O)O)c(=O)c3cc(Cl)c(N4Cc5cccnc5C4)cc32)CC1 |
| InChI | InChI=1S/C24H23ClN4O4/c1-14(30)27-7-4-16(5-8-27)29-12-18(24(32)33)23(31)17-9-19(25)22(10-21(17)29)28-11-15-3-2-6-26-20(15)13-28/h2-3,6,9-10,12,16H,4-5,7-8,11,13H2,1H3,(H,32,33) |
| InChIKey | POXHBTGXBGVUJF-UHFFFAOYSA-N |
| XLogP | 3.45 |
| TPSA | 95.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 466.93 |
| LogP ≤ 5 | 3.45 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167509452 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.